• Awatansh Tripathi, Farhad Kapadia, Anirudhha Kulkarni, Amol Bhanushali, Bhavesh Popat, Ramesh Deshpande, and Radhika Banka.
• Department of Respiratory Medicine, P.D. Hinduja Hospital and Medical Research Centre, Mumbai, India.
• Chest. 2022 Apr 1; 161 (4): e213-e217.

Case PresentationA 58-year-old man presented to us with a 1-week history of high-grade fever and progressive dry cough. Four weeks before his presentation, he was diagnosed with COVID-19 infection and needed non-ICU hospital admission with no supplemental oxygen requirements for 6 days and was treated with a 5-day course of remdesivir and 3 weeks of dexamethasone. His steroid dose was commenced on dexamethasone 12 mg bid (four times the recommended dose) for 14 days and then gradually tapered over the remaining 7 days. His history was unremarkable, except for well-controlled asthma. He did not complain of any shortness of breath, weight loss, or loss of appetite. He was never a smoker and denied any alcohol use.Copyright © 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

12 keywords...

hide…